Invention Grant
- Patent Title: Prognostic assay for squamous cell lung carcinoma
-
Application No.: US16579652Application Date: 2019-09-23
-
Publication No.: US11208690B2Publication Date: 2021-12-28
- Inventor: Seth Sadis , Paul Williams
- Applicant: LIFE TECHNOLOGIES CORPORATION
- Applicant Address: US CA Carlsbad
- Assignee: LIFE TECHNOLOGIES CORPORATION
- Current Assignee: LIFE TECHNOLOGIES CORPORATION
- Current Assignee Address: US CA Carlsbad
- Main IPC: C12Q1/6886
- IPC: C12Q1/6886 ; C12Q1/686
Abstract:
Methods for predicting clinical outcome for a human subject diagnosed with squamous cell lung carcinoma using a panel of molecular markers that includes CDKN2A and CCND1. The markers are related to the subject's increased likelihood of a negative clinical outcome.
Public/Granted literature
- US20200017903A1 PROGNOSTIC ASSAY FOR SQUAMOUS CELL LUNG CARCINOMA Public/Granted day:2020-01-16
Information query
IPC分类:
